About IQVIA
IQVIA is a publicly listed company based in Durham (United States) founded in 1982 by Dennis Gillings, and was acquired by TPG in November 2009. Clinical research and commercialization solutions are provided for healthcare. It operates in the Healthcare and Technology sectors. The company has 88,000 employees. IQVIA has completed 15 acquisitions, including Advanced Health Media, AllCare Plus and DMDConnects. Its chief executive, as recorded, is Ari Bousbib. Its website iqvia.com draws about 1.2 million monthly visits. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Medidata, Verily and TriNetX; 3 of its 3 listed competitors have raised funding.
Company details
IQVIA was founded in 1982 and is headquartered in Durham, United States. Services are offered in clinical research, real-world evidence generation, commercialization, safety, and regulatory compliance within the healthcare and life sciences sectors. Operations span research and development, with technologies and products supporting clinical, commercial, compliance, and real-world applications. Clients include pharmaceutical manufacturers, biopharma, medtech, payers, providers, and government entities across global markets.
- Annual Revenue$16.3 B (USD)5.84as on Dec 31, 2025
- Net Profit$1.36 B (USD)-0.95as on Dec 31, 2025
- EBITDA$3.42 B (USD)1.24as on Dec 31, 2025
- InvestorsTPG
& 3 more
- Employee Count88,000
- Investments & AcquisitionsAdvanced Health Media
& 14 more
- Acquired byTPG
(Nov 2009)
Associated legal entities of IQVIA
IQVIA is associated with 3 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Iqvia Rds (India) Private Limited CIN U73100KA2002PTC107115 | Active | 21 Nov 2002 | Bangalore, Karnataka, India | View details | |||
| Iqvia Analytics Services Private Limited CIN U74140KA2003PTC032950 | Active | 02 Dec 2003 | Bangalore, Karnataka | ₹1,450 Cr | 5,628 | 6 | View details |
| Iqvia Rds (India) Private Limited CIN U74909KA2002PTC107115 | Active | 21 Nov 2002 | Bangalore, Karnataka | ₹3,342 Cr | 13,703 | 4 | View details |
Apps and channels of IQVIA
IQVIA publishes 1 mobile app with over 500 downloads.
Funding Insights of IQVIA
- Total Rounds 10
- First Round $1.74M
(Apr 2006)
- Investors Count 2
All 10 funding rounds of IQVIA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | Grant | – | – | ||
| Dec 2021 | $2,794 | Grant | – | – | |
| Dec 2021 | $17,925 | Grant | – | – | |
| Dec 2021 | $232,260 | Grant | – | – | |
| Dec 2019 | $210,334 | Grant | – | – | |
| Apr 2018 | $110,964 | Grant | – | – | |
| Jul 2008 | $437,294 | Grant | – | – | |
| Jan 2008 | Private Equity Round | – | – | 3i Group | |
| Feb 2007 | $1.92M | Grant | – | – | |
| Apr 2006 | $1.74M | Unspecified | – | – | – |
4 investors in total: 4 institutional.
Investors in IQVIA
IQVIA has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include TPG, HHS and CPP Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Pension fund assets are managed for sustainable long-term growth. | 1997 | cppinvestments.com | Toronto, Canada |
Investor details for IQVIA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of IQVIA
The boards of the 2 registered companies of IQVIA currently have 7 directors; the longest-serving is Nilanjan Sinha, appointed in 2017. 41 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nilanjan Sinha DIN 07653553 | Director | 05 Jan 2017 | 9 yrs 10 mo | Iqvia Rds (India) Private Limited, Iqvia Analytics Services Private Limited |
| Prashant Parab DIN 07708099 | Director | 13 Jan 2017 | 9 yrs 9 mo | Iqvia Analytics Services Private Limited |
| David Jacob Cossitt Levy DIN 08191095 | Director | 02 Aug 2018 | 8 yrs 3 mo | Iqvia Analytics Services Private Limited |
| Gaurav Shankar Lal DIN 09060003 | Director | 09 Feb 2021 | 5 yrs 8 mo | Iqvia Rds (India) Private Limited, Iqvia Analytics Services Private Limited |
| Vardham Krishna Murthy Kumar Babu DIN 09082974 | Director | 26 Feb 2021 | 5 yrs 8 mo | Iqvia Analytics Services Private Limited |
| Madhvi Shankar DIN 09263870 | Director | 01 Jan 2025 | 1 yr 10 mo | Iqvia Rds (India) Private Limited |
| Vineet Kumar Bajpai DIN 08099634 | Director | 01 Jan 2025 | 1 yr 10 mo | Iqvia Rds (India) Private Limited |
People of IQVIA
1270 people are tracked at IQVIA (702 in leadership, 9 in board & advisors, 559 in team); the tracked headcount is 88,000.
| Name | Role | Group |
|---|---|---|
Dennis Gillings | Founder | Leadership |
Ari Bousbib | CEO | Leadership |
Peter Scilipote | Vice President, Business Transformation | Leadership |
Lynda Curtin | Director Clinical Operations -site Management | Leadership |
Oana Borse | Director, Strategic Sourcing R&ds | Leadership |
David Peig | Senior Director - Rare Disease BU & GTM Strategy | Leadership |
Mike Davis | Sr. Director, Strategic Business Development (r&d Solutions) | Leadership |
Ryan Deterding | Vice President And Global Account Director | Leadership |
Iqbal Thaker | Assoc. Director - IT Projects | Leadership |
Jennifer Millard | Vice President | Leadership |
Arthur Jenkins | Senior Director, Porfolio Project Management And Development Engineering | Leadership |
Manoj Singh | Director Of Software Engineering | Leadership |
Ester Pavon | Associate Director, Clinical Project Management | Leadership |
Nuno Dias | Senior Director, IT (head Of Technology) | Leadership |
Alexey Levashov | Associate Clinical Project Management Director | Leadership |
Chris Nickum | Vice President And General Manager, Commercial Solutions And Insights Hub (csih) | Leadership |
Fumihiko Ugajin | President - Japan | Leadership |
Stormie R. Crouch | Senior Director, Business Development | Leadership |
Avery Pasch | Account Director | Leadership |
Abbygail Boswell | International Project Associate Director | Leadership |
1250 more people are available in the full profile.
Complete people profiles for IQVIA
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of IQVIA
IQVIA is a publicly listed company on the NYSE with ticker symbol IQV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Nov 2020
- Listed onB3: I1QV34
- Listed entityIQVIA Holdings, Inc.
- Exchange sectorHealth technology
- ISINUS46266C1053
- Share price$260.68 (-0.58% on the day) · 2026-10-13
- Market capitalisation$42.91B
- Price to earnings32.3
- EPS (diluted, trailing year)$8.06
- Volume (last session)1,359,673
Financials of IQVIA
Figures of Iqvia Rds (India) Private Limited, the primary company behind IQVIA, for FY 2025. Revenue was ₹3,342 Cr (+6% year on year). Net profit was ₹347 Cr (10% margin). EBITDA was ₹520 Cr (16% margin). Revenue has grown at a compounded annual rate of +11% over three years and +16% over five years.
- ₹3,342 CrRevenue · FY 2025 · +6% YoY
- ₹347 CrNet profit · 10% margin
- ₹520 CrEBITDA · 16% margin
- ₹2.38 CrPaid-up capital
- 13,703Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $16.30B | $1.36B | $3.42B |
| 2024 | $15.40B | $1.37B | $3.38B |
| 2023 | $14.96B | $1.36B | $3.17B |
| 2022 | $14.42B | $1.09B | $2.97B |
| 2021 | $13.88B | $966.0M | $2.68B |
Balance sheet, profit and loss, cash flow and ratios of Iqvia Rds (India) Private Limited are on its company page.
Detailed financial statements for IQVIA
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IQVIA
IQVIA has strategically engaged in corporate development activities, having acquired 15 companies. Notable acquisitions include Advanced Health Media, AllCare Plus and DMDConnects.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
AI-based data analytics tools for integration and visualization are provided. | whiz.ai | New York, United States | 2017 | May 2025 | •••• | |
Healthcare marketing solutions are provided for personalized engagement. | lassoplatform.io | Austin, United States | 2019 | Oct 2022 | •••• | |
Software for drug informatics platforms is supplied to pharmaceutical firms. | pharmaspectra.com | London, United Kingdom | 2005 | Aug 2022 | $100M | |
Mailing lists and contact data are supplied for healthcare professionals. | dmdconnects.com | Rosemont, United States | 2011 | Aug 2021 | •••• | |
Laboratory services including central labs and biomarkers are provided. | q2labsolutions.com | Morrisville, United States | 2015 | Apr 2021 | $760M | |
Medications and health services are provided by this standalone pharmacy. | allcarepluspharmacy.com | Northborough, United States | 2008 | Sep 2020 | •••• | |
NLP-based text mining solutions are provided for knowledge discovery. | linguamatics.com | Cambridge, United Kingdom | 2001 | Feb 2019 | •••• | |
CRO offering data management, biostatistics, and statistical programming services | statfinn.fi | Espoo, Finland | 2005 | May 2018 | •••• | |
technology and service solutions designed to manage compliant interactions with healthcare professionals and organizations for life sciences industry | ahmdirect.com | New Providence, United States | 1999 | May 2018 | •••• | |
Business intelligence software for healthcare and enterprise functions is provided. | optimumcontact.com | Northwood, United Kingdom | 2003 | Mar 2018 | •••• |
Complete acquisition details for IQVIA
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of IQVIA
15 dated milestones of IQVIA across 43 years, from founding to its latest funding, stage changes and deals.
- Founded IQVIA is founded.
- Funding First funding round of $1.7M.
- Exit Acquired by TPG.
- Acquisition Acquires Optimum Contact.
- Acquisition Acquires Advanced Health Media.
- Acquisition Acquires StatFinn.
- Acquisition Acquires Linguamatics.
- Acquisition Acquires AllCare Plus.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Q² Solutions.
- Acquisition Acquires DMDConnects.
- Acquisition Acquires Pharmaspectra.
- Acquisition Acquires IQVIA Digital.
- Funding Latest funding round, Grant,.
- Acquisition Acquires WhizAI.
Competitors of IQVIA
IQVIA has 3 listed competitors in our database, 3 of them funded. They include Medidata, Verily and TriNetX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | AI-based solutions for health management are provided. | ||
| trinetx.com | 2013 | Cambridge, United States | $53M | 95 | Clinical trial management software is provided for researchers and professionals. |
Detailed competitors of IQVIA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IQVIA
The website of IQVIA (iqvia.com) receives about 1.2M visits a month and ranks #45,953 among all websites worldwide, #1,171 in Biotechnology and Pharmaceuticals.
- Monthly visits1.2M
▲ 22.3% vs previous month
- Unique visitors428.2K
per month
- Global rank#45,953
among all websites
- Category rank#1,171
Health · Biotechnology and Pharmaceuticals
- Bounce rate42%
- Pages per visit4.6
- Average visit3 min 37 sec
- DevicesDesktop 60% · Mobile 40%
Websites whose visitors overlap most with IQVIA. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| syneoshealth.com | 100% | 199.6K | #198,509 | View details | |
| suvoda.com | 91% | 100.2K | #299,441 | View details | |
| novartis.com | 90% | 948.8K | #58,822 | View details | |
| medrio.com | 90% | 133.1K | #199,158 | View details | |
| abbvie.com | 90% | 851.9K | #69,141 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for IQVIA
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as IQVIA (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Iqvia
Complete news archive for IQVIA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IQVIA
IQVIA was founded in 1982 and raised its 1st funding round 24 years after it was founded.
IQVIA is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Ari Bousbib is the CEO of IQVIA, as recorded in our data.
IQVIA has 88,000 employees.
Annual revenue of IQVIA is $16.3B as on Dec 31, 2025.
IQVIA was founded in 1982 and is headquartered in Durham, United States. Services are offered in clinical research, real-world evidence generation, commercialization, safety, and regulatory compliance within the healthcare and life sciences sectors. Operations span research and development, with technologies and products supporting clinical, commercial, compliance, and real-world applications. Clients include pharmaceutical manufacturers, biopharma, medtech, payers, providers, and government entities across global markets.
Yes, IQVIA is publicly traded on NYSE under the ticker symbol IQV.
IQVIA has made 15 acquisitions, including Advanced Health Media, AllCare Plus, and DMDConnects.
IQVIA has 4 investors. Key investors include TPG, HHS, CPP Investments, and European Union.
IQVIA is associated with 2 legal entities: Iqvia Rds (India) Private Limited, Iqvia Analytics Services Private Limited.
Yes. IQVIA was acquired by TPG in November 2009.